Funding · Company
AEON Biopharma, Inc.
Irvine, CABiotech & Pharma
AEON Biopharma, Inc. of Irvine, CA has disclosed $55M across 2 Form D offerings filed with the SEC between Aug 11, 2022 and Aug 11, 2022.
$55M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$25M
Form D · Aug 11, 2022 ↗
Q3 2022
· target $25M
Filing details
HeadquartersIrvine, CAIndustryBiotech & Pharma (Pharmaceuticals)SEC CIK0001622667Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →